Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

penile cancer News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Yesterday

A phase II trial, MH-Penile-002, investigates a neoadjuvant treatment combining an anti-EGFR antibody-drug conjugate with a PD-1 inhibitor for penile cancer. This study focuses on patients facing challenges with penile preservation or regional lymph node metastasis.

This week

The PERICLES trial identifies pre-existing immunity and high-risk HPV status as key factors influencing immunotherapy response in advanced penile cancer. These findings could guide future treatment strategies and patient selection.

Earlier

A recent study highlights the epidemiological trends in penile cancer and discusses the evolving role of dynamic sentinel lymph node biopsy in its management. This research provides insights into the changing landscape of diagnosis and treatment for this rare disease.

A systematic review highlights the role of microRNAs in penile cancer, providing insights into their potential as diagnostic and prognostic biomarkers. This research could pave the way for improved understanding and management of penile cancer.

A recent study highlights significant variations in the care of penile cancer, identifying critical knowledge gaps and setting research priorities. This research aims to improve treatment outcomes and standardize care practices for affected patients.

Research highlights B7-H3 (CD276) as a promising target for T cell-based bispecific antibody therapy in penile cancer. This discovery could pave the way for new treatment options in a rare cancer type.

The Australian Penile Cancer Clinical Registry aims to enhance data collection on penile cancer, facilitating better understanding and treatment of the disease. This comprehensive national approach is expected to improve patient outcomes through improved data insights.

Not rare diseases news,news about your rare disease.